Yuko Hoshino-Takada

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Long-term safety and effectiveness of rimegepant for the preventive treatment of migraine in Japan: an open-label extension of a phase 3 study.

Long-term safety and effectiveness of rimegepant for the preventive treatment of migraine in Japan: an open-label extension of a phase 3 study.

Journal: The journal of headache and pain

Published: December 17, 2025

Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.

Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.

Journal: Endocrine journal

Published: November 03, 2025

Visualization of Neural Activity in the Upper and Middle Lumbar Spine Using Magnetospinography After Lateral Femoral Cutaneous, Saphenous, and Femoral Nerve Stimulation.

Visualization of Neural Activity in the Upper and Middle Lumbar Spine Using Magnetospinography After Lateral Femoral Cutaneous, Saphenous, and Femoral Nerve Stimulation.

Journal: Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society

Published: October 16, 2025

Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.

Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.

Journal: Headache

Published: September 21, 2025

Improvement in body composition of Japanese participants with Prader-Willi syndrome following somatropin treatment: an open-label, multi cohort Phase 3 study.

Improvement in body composition of Japanese participants with Prader-Willi syndrome following somatropin treatment: an open-label, multi cohort Phase 3 study.

Journal: Endocrine journal

Published: May 28, 2025

Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.

Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.

Journal: Headache

Published: January 23, 2025

Magnetoneurography as a novel functional imaging technique for cervical myelopathy.

Magnetoneurography as a novel functional imaging technique for cervical myelopathy.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published: January 11, 2025

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial.

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial.

Journal: Headache

Published: November 28, 2024

Enhanced biodegradable polyester film degradation in soil by sequential cooperation of yeast-derived esterase and microbial community.

Enhanced biodegradable polyester film degradation in soil by sequential cooperation of yeast-derived esterase and microbial community.

Journal: Environmental science and pollution research international

Published: August 07, 2023

Assessing ulnar neuropathy at the elbow using magnetoneurography.

Assessing ulnar neuropathy at the elbow using magnetoneurography.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published: July 25, 2023

Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study.

Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study.

Journal: Hormone research in paediatrics

Published: November 15, 2021

A Comparison of Safety Information in Drug Labeling at the Initial Approval of New Drugs Approved Both in Japan and the United States.

A Comparison of Safety Information in Drug Labeling at the Initial Approval of New Drugs Approved Both in Japan and the United States.

Journal: Therapeutic innovation & regulatory science

Published: November 08, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026